MedPath

Pathophysiology during neural information processing in ADHD

Recruiting
Conditions
F90
Hyperkinetic disorders
Registration Number
DRKS00014922
Lead Sponsor
Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
32
Inclusion Criteria

Amendment 1+2:
1) Age 18-45
2) Sufficient understanding of the German language for the questionnaire survey
3) Written informed consent of patients
4) Diagnosis of ADHD according to ICD-10
5) Clinically indicated treatment with methylphenidate
6) Stable psychotropic medication (except ADHD medication) for at least 4 weeks

Amendment 1:
unmedicated, concerning methylphenidate

Amendment 2:
Medicated for at least 6 months with methylphenidate

Exclusion Criteria

1. known neurological disorders affecting the brain, including condition after craniocerebral trauma with unconsciousness greater than 5 minutes
2. harmful substance use according to ICD-10
3. taking antipsychotics up to 4 weeks before baseline and during the examination period

For Amendment 1:
4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extended release) or within 48 hours (extended release and atomoxetine) before baseline
For Amendment 2:
4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extemded release) or within 48 hours (extended release and atomoxetine) before baseline, with the exception of methylphenidate

5. motor hyperactivity at the time of measurement that makes an EEG examination impossible
6. known IQ < 70
7. premature birth < 32 wks

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evidence of specific changes in the EEG relative to medication
Secondary Outcome Measures
NameTimeMethod
Relationship between EEG parameters, dosage of medication, neuropsychology and interviews on the current condition (ADHS-E, Wender Utah Rating Scale short form (WURS-K), Wender-Reimherr-Interview (WRI-V), Testbatterie zur Aufmerksamkeitsprüfung (TAP))
© Copyright 2025. All Rights Reserved by MedPath